Kaletra® (lopinavir/ritonavir) – First-Time Generic
January 15, 2017 – Lannett launched an AA-rated generic version of AbbVie’s Kaletra (lopinavir/ritonavir) oral solution for the treatment of HIV-1 infection in adults and pediatric patients (≥ 14 days old) when used in combination with other antiretroviral agents.
Top